Karolinska Institutet, Department of Clinical Science, Intervention and Technology, Division of Speech and Language Pathology, Stockholm, Sweden; Stockholms Sjukhem, R&D unit, Stockholm, Sweden.
Karolinska Institutet, Department of Clinical Science, Intervention and Technology, Division of Speech and Language Pathology, Stockholm, Sweden; Karolinska University Hospital, Theme Women's Health and Allied Health Professionals, Medical unit Speech & Language Pathology, Stockholm, Sweden.
J Voice. 2024 Jul;38(4):965.e1-965.e13. doi: 10.1016/j.jvoice.2021.10.016. Epub 2021 Nov 28.
To evaluate the process and scientific feasibility of using a portable voice accumulator (PVA) to study carry-over of treatment effects on speech and voice in people with mild-moderate Parkinson's disease.
The study was guided by the checklist in Consolidated Standards of Reporting Trials (CONSORT) 2010 statement: extension to randomized pilot and feasibility trials. Participants with Parkinson's disease were recruited within the context of a randomized controlled trial with random allocation to intervention with either HiCommunication, a program targeting speech and communication, or HiBalance, a program targeting balance and strength. Before and after intervention data was collected from standardized studio recordings of speech and registrations of voice use in daily life with the PVA VoxLog.
Fifteen participants were included in the study and sufficient data was yielded from six of them. Reasons for insufficient data included technical issues and difficulties handling the PVA. Changes in voice sound level from pre to post intervention differed at an individual level when assessed in daily life compared to studio recordings. Registrations in daily life provided information on phonation ratio and ability to adapt voice sound level to environmental noise.
This study highlights the challenges of studying intervention effects on voice use in daily life using a PVA. Improvements of test protocols in future studies are suggested. We exemplify how PVA data may generate a more detailed and ecologically valid picture of voice use complementing studio recordings of speech. Finally, we encourage technical development of more user-friendly PVAs.
评估使用便携式语音记录仪(PVA)研究轻度至中度帕金森病患者治疗效果对言语和嗓音的延续性的过程和科学可行性。
本研究遵循 CONSORT 2010 声明的扩展内容:随机试验和可行性试验。在一项随机对照试验的背景下招募帕金森病患者,该试验采用随机分组,分别接受旨在改善言语和交流的 HiCommunication 计划或旨在改善平衡和力量的 HiBalance 计划。在干预前后,从标准化的语音工作室录音和使用 PVA VoxLog 在日常生活中记录嗓音使用情况中收集数据。
本研究纳入了 15 名参与者,其中 6 名参与者提供了足够的数据。数据不足的原因包括技术问题和 PVA 操作困难。与工作室录音相比,日常生活中评估的嗓音声级从干预前到干预后的个体差异。日常生活中的记录提供了发声比和适应环境噪声的嗓音声级的能力的信息。
本研究强调了使用 PVA 研究日常生活中干预对嗓音使用的影响所面临的挑战。建议在未来的研究中改进测试方案。我们举例说明了 PVA 数据如何生成更详细和更具生态有效性的嗓音使用情况,补充了语音的工作室录音。最后,我们鼓励开发更用户友好的 PVA。